AbbVie Reports Third-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AbbVie (ABBV) Tops Q3 EPS by 7c, Raises FY Guidance
October 30, 2020 7:48 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $2.83, $0.07 better than the analyst estimate of $2.76. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $12.72 billion.
GUIDANCE:
AbbVie sees FY2020 EPS of $10.47-$10.49, versus the consensus of... More
